Aug 15
Opportunity
Participants expect some flexibility and do not want clinical trial participation to significantly impact their normal daily schedule. Sponsors should consider exploring solutions that allow participants to more easily find and select times for appointments, especially with increased flexibility and more diverse procedure locations.
Considerations to Help Action the Opportunity
- Understand the individual needs of each participant and their preferences
- Partner with sites to build flexibility into the clinical trial design by providing timing and location options for visits
- Explore decentralized clinical trial options, such as telemedicine and the use of local clinics and sites
Value and Potential Benefits
- Increases flexibility and ease of scheduling
- Encourages patient engagement and empowers patients
- Reduces the barriers to finding and attending appointments potentially leading to better compliance and retention
Related Blog Posts
TransCelerate Highlights Digital Momentum and Global Collaboration in 2025 Annual Report
TransCelerate BioPharma has released its 2025 annual report, titled The Power of Forward, outlining a year defined by continued digital adoption, regulatory collaboration, and expansion of pragmatic approaches to clinical development. Read the full article featuring Janice Chang from Applied Clinical Trials here.
When Friction Meets Force in Clinical Research
More than a decade ago, a group of pharma R&D heads gathered for an annual meeting focused on addressing common industry challenges. They had a running joke: With an average tenure of just three years, if they wanted to see each other at more than one of these gatherings, they’d better figure out how to…
Scrip Asks… What Does 2026 Hold For Biopharma? Part 4: R&D Innovation
Enthusiastic predictions from industry leaders for ongoing progress in obesity, oncology, immunology, neuroscience and more were supported by optimism for the potential of AI and other technological advances to enable breakthroughs in processes as well as pipelines. Read the full article featuring Rob DiCicco from Citeline here.
